SPX3,963.51+29.59 0.75%
DIA338.46+2.02 0.60%
IXIC11,082.00+123.45 1.13%

UBS Downgrades Corteva to Neutral, Raises Price Target to $73

Benzinga · 11/16/2022 04:36
UBS analyst Joshua Spector downgrades Corteva (NYSE:CTVA) from Buy to Neutral and raises the price target from $70 to $73.